|
SRP72 expression based on
|
KIRP : Kidney renal papillary cell carcinoma
| Comparison | Statistical significance |
| Normal-vs-Primary | 2.99230000000428E-07 |
|
KIRP : Kidney renal papillary cell carcinoma Note
Cancer stage information is not available for 89 samples.
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-Stage1 |
2.52459999572352E-08 |
| Normal-vs-Stage2 |
4.047700E-02 |
| Normal-vs-Stage3 |
1.118650E-01 |
| Normal-vs-Stage4 |
7.582400E-01 |
| Stage1-vs-Stage2 |
2.334200E-01 |
| Stage1-vs-Stage3 |
5.747900E-02 |
| Stage1-vs-Stage4 |
3.800400E-03 |
| Stage2-vs-Stage3 |
7.046000E-01 |
| Stage2-vs-Stage4 |
1.367970E-01 |
| Stage3-vs-Stage4 |
2.360600E-01 |
|
|
KIRP : Kidney renal papillary cell carcinoma Note
Patient race information is not available for 15 samples and two samples from American Indians not included in the above plot.
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-Caucasian |
2.07180000044715E-07 |
| Normal-vs-AfricanAmerican |
2.405000E-04 |
| Normal-vs-Asian |
4.241200E-03 |
| Caucasian-vs-AfricanAmerican |
6.414800E-01 |
| Caucasian-vs-Asian |
7.872000E-01 |
| AfricanAmerican-vs-Asian |
6.613800E-01 |
|
|
KIRP : Kidney renal papillary cell carcinoma
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-Male |
1.92729998627073E-09 |
| Normal-vs-Female |
2.305600E-01 |
| Male-vs-Female |
1.626720E-04 |
|
|
KIRP : Kidney renal papillary cell carcinoma Note
Patient BMI information is not available for 72 samples.
| Descriptions |
| Normal weight |
BMI greater than equal to 18.5 and BMI less than 25 |
Extereme weight |
BMI greater than equal to 25 and BMI less than 30 |
| Obese |
BMI greater than equal to 30 and BMI less than 40 |
Extreme Obese |
BMI greater than 40 |
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-Normal_Weight |
1.598880E-03 |
| Normal-vs-Extreme_Weight |
3.45660000622416E-09 |
| Normal-vs-Obese |
4.764200E-03 |
| Normal-vs-Extreme_Obese |
5.1258000000054E-07 |
| Normal_Weight-vs-Extreme_Weight |
9.708000E-02 |
| Normal_Weight-vs-Obese |
7.015400E-01 |
| Normal_Weight-vs-Extreme_Obese |
2.688000E-02 |
| Extreme_Weight-vs-Obese |
3.828400E-02 |
| Extreme_Weight-vs-Extreme_Obese |
3.746400E-01 |
| Obese-vs-Extreme_Obese |
1.006030E-02 |
|
|
KIRP : Kidney renal papillary cell carcinoma Note
Patient age information is not available for 3 samples.
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-Age(21-40Yrs) |
9.017800E-01 |
| Normal-vs-Age(41-60Yrs) |
9.93780000000388E-05 |
| Normal-vs-Age(61-80Yrs) |
4.16150003346161E-09 |
| Normal-vs-Age(81-100Yrs) |
3.27379999998101E-06 |
| Age(21-40Yrs)-vs-Age(41-60Yrs) |
1.582580E-01 |
| Age(21-40Yrs)-vs-Age(61-80Yrs) |
4.708100E-02 |
| Age(21-40Yrs)-vs-Age(81-100Yrs) |
2.729600E-02 |
| Age(41-60Yrs)-vs-Age(61-80Yrs) |
2.642100E-02 |
| Age(41-60Yrs)-vs-Age(81-100Yrs) |
1.317630E-01 |
| Age(61-80Yrs)-vs-Age(81-100Yrs) |
5.166200E-01 |
|
|
KIRP : Kidney renal papillary cell carcinoma NOTE
Histology information is not available for 17 samples.
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-VS-Type1 PRCC |
4.71859995521129E-10 |
| Normal-VS-Type2 PRCC |
9.88979999999584E-05 |
| Normal-VS-KIRP CIMP |
1.846370E-01 |
| Normal-VS-Unclassified PRCC |
4.518400E-02 |
| Type1 PRCC-VS-Type2 PRCC |
3.705800E-02 |
| Type1 PRCC-VS-KIRP CIMP |
1.619790E-02 |
| Type1 PRCC-VS-Unclassified PRCC |
9.182100E-03 |
| Type2 PRCC-VS-KIRP CIMP |
3.574400E-02 |
| Type2 PRCC-VS-Unclassified PRCC |
3.741600E-01 |
| KIRP CIMP-VS-Unclassified PRCC |
6.249900E-02 |
|
Histologic PRCC subtypes: Ricketts CJ et al, The Cancer Genome Atlas Comprehensive Molecular Characterization of Renal Cell Carcinoma. Cell Rep. 2018 Apr 3;23(1):313-326.e5. doi: 10.1016/j.celrep.2018.03.075
|
KIRP : Kidney renal papillary cell carcinoma Note
Nodal metastais status is not available for 1 sample and cancer in nearby lymph nodes cannot be measured (NX) in 211 samples.
| pathologic_N descriptions |
| N0 | No regional lymph node metastasis |
N1 | Metastases in 1 to 3 axillary lymph nodes |
| N2 | Metastases in 4 to 9 axillary lymph nodes |
N3 | Metastases in 10 or more axillary lymph nodes |
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-N0 |
2.66149999994525E-06 |
| Normal-vs-N1 |
8.505800E-01 |
| Normal-vs-N2 |
7.198200E-01 |
| N0-vs-N1 |
4.082200E-02 |
| N0-vs-N2 |
3.427700E-02 |
| N1-vs-N2 |
6.825800E-01 |
|
|
